Tapentadol 200mg

Tapentadol 200mg

Price range: €65 through €420

Quantity
Choose an option
Tapentadol 200mg
Add to cart
Buy Now
SKU: N/A Category: Tag:

Product Description

Tapentadol 200mg

Tapentadol 200mg (brand names: Nucynta, Palexia) is a prescription opioid analgesic used to treat moderate to severe acute pain in adults, and sometimes chronic pain conditions like musculoskeletal pain or diabetic neuropathy when other treatments fail. The 200 mg strength is typically an extended-release (ER) formulation (e.g., Nucynta ER), taken once or twice daily, not for as-needed use.

Key Facts and Evidence

  • Mechanism: Dual-action μ-opioid receptor agonist + norepinephrine reuptake inhibitor (NRI). This provides pain relief with potentially less respiratory depression than pure opioids like morphine (studies: e.g., Steiner et al., Pain 2011; Afilalo et al., J Pain 2010).
  • Standard Dosing (per FDA/EMA labels):
Condition Starting Dose Max Daily Dose Notes
Acute Pain (IR) 50-100 mg every 4-6 hrs 600-700 mg Immediate-release (IR); not 200 mg.
Chronic Pain (ER) 50-100 mg every 12 hrs 500 mg Titrate up; 200 mg BID possible in tolerant patients.

200 mg ER is a mid-to-high dose; requires prior titration to avoid overdose.

  • Efficacy: Meta-analyses (e.g., Cochrane Database Syst Rev 2015) show it’s effective for nociceptive/neuropathic pain, comparable to oxycodone but with better GI tolerability.

Warnings and Risks (Substantiated by Data)

  • High Abuse Potential: Schedule II controlled substance (DEA). Risk of addiction, overdose—dozens of deaths linked to supratherapeutic doses (FDA adverse events database; CDC opioid reports).
  • Side Effects (common >10% incidence):
Mild/Moderate Serious (>1%)
Nausea (21%), dizziness (16%), somnolence (11%) Respiratory depression, serotonin syndrome (if with SSRIs), seizures (0.1-1%), hypotension.
  • Contraindications: Severe respiratory depression, acute intoxication, paralytic ileus, recent MAOI use. Avoid in elderly, liver/kidney impairment (reduce dose 50%; PK studies show prolonged half-life ~7 hrs).
  • Overdose Signs: Pinpoint pupils, coma, apnea. Naloxone reverses (per SAMHSA guidelines).
  • Interactions: Potentiated by alcohol, benzos, other opioids (respiratory risk ↑5x; NEJM 2017).

Legality and Access

  • Prescription-only worldwide. 200 mg ER not for opioid-naïve patients (start low per guidelines: CDC 2022 Opioid Prescribing).
  • Do not self-medicate. Evidence from overdose data (e.g., 20,000+ US opioid ER visits/year) shows non-prescribed use is deadly.

Consult a doctor/pharmacist for personalized advice. This is general info from FDA labels, PubMed, and clinical trials—not medical advice. If experiencing pain or side effects, seek immediate care.

Additional Information

Quantity

2, 5, 10, 15, 20

Top